Anti-tumor Immunity against CT26 Colon Tumor in Mice Immunized with Plasmid DNA Encoding β-Galactosidase Fused to an Envelope Protein of Endogenous Retrovirus-Reference-Cited by-同舟云学术

Anti-tumor Immunity against CT26 Colon Tumor in Mice Immunized with Plasmid DNA Encoding β-Galactosidase Fused to an Envelope Protein of Endogenous Retrovirus

Published:2000-08 Issue:1 Volume:204 Page:11-18
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Takeda Junko,Sato Yukio,Kiyosawa Hidenori,Mori Tetsuji,Yokoya Sachihiko,Irisawa Atsushi,Miyata Masayuki,Obara Katsutoshi,Fujita Teizo,Suzuki Toshimitsu,Kasukawa Reiji,Wanaka Akio

Publisher

Elsevier BV

Subject

Immunology

Reference38 articles.

1. Tumor antigens recognized by T lymphocytes;Boon;Annu. Rev. Immunol.,1994

2. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas;Brichard;J. Exp. Med.,1993

3. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines;Cox;Science,1994

4. Cancer antigens: Immune recognition of self and altered self;Houghton;J. Exp. Med.,1994

5. Tumour antigens: A new look for the 1990s;Pardoll;Nature,1994

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation;Journal of Cell Biology;2022-04-21

2. Antigen-derived peptides directly engage the unfolded-protein sensor IRE1α to curb cross-presentation by dendritic cells;2021-09-10

3. Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation;Journal of Controlled Release;2021-05

4. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression;Journal for ImmunoTherapy of Cancer;2021-02

5. Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines;Translational Oncology;2021-01